株式会社コンヴァノ News Releases

Announcement Regarding Executive Appointments and Management Structure

Convano Co., Ltd. (Headquarters: Shibuya-ku, Tokyo; President and CEO: Ayumu Kamishigoto; Securities… · 2026-06-29

Convano Completes Acquisition of Accel Mark Inc. as Consolidated Subsidiary

Convano Inc. (Headquarters: Shibuya-ku, Tokyo; President and CEO: Kaminoshimo Aya; Securities Code: … · 2026-07-02

Securities Report - 13th Fiscal Period (2025/04/01 - 2026/03/31)

Convano Inc. has filed its Securities Report for the 13th fiscal period (April 1, 2025 - March 31, 2… · 2026-06-30

Convano Makes Axel Mark a Consolidated Subsidiary

Convano announced that it will acquire Axel Mark through an allocation of new shares to a third part… · 2026-05-29

Convano Announces Mid-Term Management Plan Through FY March 2029

Convano Inc. has announced its mid-term management plan covering the period from FY March 2027 to FY… · 2026-05-29

Convano Announces FY2026 Results: Non-GAAP Operating Profit Surges 49x Driven by AI and Healthcare Network

Convano發布2026財年財報，受惠於AI與顧問事業成長，營收達155億日圓，營業利益暴增約49倍。 · 2026-05-15

THINX HEALTHCARE Establishes System for Domestic Approval of Botulinum Toxin Preparations

Convano's subsidiary partners with a specialized institution to obtain domestic approval for botulin… · 2026-03-28

Synx Healthcare Establishes System for Domestic Approval Acquisition of Botulinum Toxin Preparations

Convano's subsidiary partners with a specialized institution to obtain domestic approval for botulin… · 2026-03-28

Convano Announces FY2026 Results: Non-GAAP Operating Profit Surges 49x Driven by AI and Healthcare Network

Convano Inc. announced its full-year financial results for the fiscal year ending March 2026, report… · 2026-05-15